HAIFA, Israel, November 27, 2017 /PRNewswire/ --
INSIGHTEC, the world leader of MR-guided Focused Ultrasoundannounced today that it has received approval from the U.S. Food and Drug Administration (FDA) to initiate a study to evaluate the safety and feasibility of the Exablate Neuro for disrupting the blood brain barrier (BBB) in patients with Glioblastoma.
In the current trial, the research team will inject a commonly used sonographic microbubble solution into the bloodstream of a patient with a malignant brain tumor. Ultrasound waves will then be delivered to oscillate the microbubbles causing temporary disruption of the blood brain barrier. The trial will include up to 15 subjects with suspected glioblastoma who are scheduled to undergo tumor resection. The Principal Investigator is Graeme F. Woodworth, MD, FACS, Associate Professor of Neurosurgery and Director of The Brain Tumor Treatment & Research Center at the University of Maryland School of Medicine, and Attending Neurosurgeon at the University of Maryland Medical Center in Baltimore, Maryland.
"Clinical research is critical for pushing the boundaries of MR-guided focused ultrasound technology," said Maurice R. Ferré MD, INSIGHTEC's CEO and Chairman of the Board. "INSIGHTEC continues to collaborate with leading researchers to trial new clinical applications that may have significant impact where it matters most - patient lives."
INSIGHTEC is the world leader and innovator of MR-guided Focused Ultrasound (MRgFUS). The company's non-invasive platforms, Exablate and Exablate Neuro, are proven technology based on sound clinical evidence for treating essential tremor, painful bone metastases and uterine fibroids. The company is dedicated to improving patient lives by collaborating with physicians, medical institutions, academic researchers and regulatory bodies around the world.
For more information, please visit: http://www.insightec.com .
Media Contact: Michelle Barry Red Lorry Yellow Lorry for INSIGHTEC email@example.com +1(857)-217-2886
Subscribe to our Free Newsletters!
Hypopituitarism is a rare disorder resulting from decreased secretion of one or more of the ...
Palliative care is a specialized multifaceted care for patients with chronic or terminal illness to ...
Our kitchen and food has the best medicinal properties to fight stress. These are the top 10 foods ...View All